Follicular lymphoma - rituximab (review): response to consultee, commentator and public comments on the appraisal consultation document (ACD)
|
Follicular lymphoma - rituximab (review): response to consultee, commentator and public comments on the appraisal consultation document (ACD)
01 December 2011 (162.35 Kb 47 sec) |
This page was last updated: 28 November 2011